In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Knoll

This article was originally published in The Tan Sheet

Executive Summary

Files ANDA suitability petition March 22 for "solubilized" ibuprofen - a.k.a. Whitehall's Advil Liqui-Gels. Knoll's proposed branded ibuprofen product would differ from the reference drug in that it would be in tablet form, processed from a solid, "extruded" form of the liquid ibuprofen solution used in the currently marketed soft gel product. The firm's petition includes data showing what Knoll describes as "substantial equivalence" between the proposed ibuprofen product, Advil Liqui-Gels and two other ibuprofen products. The new tablet is said to have faster absorption than standard ibuprofen tablets, similar to the liquid gel product. Knoll has published for third-party review a variety of trademarks for pharmaceuticals and dietary supplements manufactured using "melt extrusion" technology

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS089682

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel